Clinical Trial: A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or Two Antihypertensive Medications

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07835984) titled 'A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or Two Antihypertensive Medications' on Sept. 17.

Brief Summary: The purpose of this study is to evaluate the effect of GW906 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of GW906 as add-on therapy.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Hypertension

Intervention: DRUG: GW906

Subcutaneous injection. 24 weeks

DRUG: Placebo

Subcutaneous injection. 24 weeks

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ...